Late effects of oncological therapy in children;Spätfolgen nach onkologischer Therapie im Kindesalter

Padiatrische Praxis

Volumn 64, Issue 1, 2003, Pages 47-64

  Kremers, Anja ^a   Langer, T ^b   Stohr W ^b   Beck, J D ^b   Rascher, W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Universitäts Kinderklinik ^*

Author keywords

Aftercare; Childhood cancer; Late effects after antineoplastic therapy; Vertical network; Late Effects Surveillance System (LESS)

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; METILDIGOXIN; VINCRISTINE;

ADOLESCENCE; AFTERCARE; ARTICLE; AUSTRIA; CANCER PATIENT; CANCER THERAPY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; EWING SARCOMA; FOLLOW UP; GERMANY; HEARING IMPAIRMENT; HEART DISEASE; HUMAN; KIDNEY DYSFUNCTION; LEUKOENCEPHALOPATHY; LONG TERM CARE; OSTEOSARCOMA; PATIENT CARE; PROSPECTIVE STUDY; SOFT TISSUE SARCOMA; STANDARDIZATION; SWITZERLAND; TUMOR BIOPSY;

EID: 0345530743     PISSN: 00309346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Beck JD, et al. After-care of children and young adults surviving cancer. Initial recommendations by the late sequelae study group. Klin Padiatr 1995; 207: 186-192.
2. Steinherz LJ, et al. Anthracycline-related cardiac damage. In: Bricker JT, et al. Cardiac toxicity after treatment for childhood cancer. New York: Wiley-Liss; 1993. p. 63-72.
3. Blatt J, et al. Late effects of childhood cancer and its treatment. In: Poplack D, Pizzo P, editors. Principles and Practice of Paediatric Oncology. Philadelphia: Lippincott-Raven; 1997. p. 1303-1329.
4. Lipshultz SE, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer (see comments). N Engl J Med 1995; 332: 1738-1743.
5. Robert J. Epirubicin. Clinical pharmacology and dose-effect relationship. Drugs 1993; 45 (Suppl): 220-230.
6. Mertens AC, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163-3172.
7. Hausdorf G. Late Effects of Anthracycline Therapy in Childhood: Evaluation and Current Therapy. In: Bricker JT, et al. Cardiac Toxicity after Treatment for childhood Cancer. New York-Chichester-Brisbane-Toronto-Singapore: Wiley-Liss; 1993. p. 73-85.
8. Schell MJ, et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 1989; 7: 754-760.
9. Delb W, et al. Comparative studies of the ototoxicity of cisplatin and carboplatin. Laryngorhinootologie 1993; 72: 24-27.
10. Kwong DL, et al. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 1996; 36: 281-289.
11. Rossi R, et al. Ifosfamide-induced nephrotoxicity. Monatsschr Kinderheilkd 1993; 141: 594-601.
12. Stevens MC, Brandis M. Incidence and etiology of ifosfamide nephrotoxicity: report of a meeting held in Rhodes, Greece, October 3rd, 1991. Med Pediatr Oncol 1993; 21: 640-644.
13. Skinner R, et al. Cisplatin dose rate as a risk factor for nephrotoxicity in children. Br J Cancer 1998; 77: 1677-1682.
14. Schwartz GJ, et al. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571-590.
15. Noorda EM, et al. Adult height and age at menarche in childhood cancer survivors. Eur J Cancer 2001; 37: 605-612.
16. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 1991; 118: 226-228.
17. Abayomi OK and Sadeghi NA. The incidence of late endocrine dysfunction following irradiation for childhood medulloblastoma. Int J Radiat Oncol Biol Phys 1986; 12: 945-948.
18. Leung W, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 2000; 18: 3273-3279.
19. Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am 1997; 44: 489-503.
20. Ash P. The influence of radiation on fertility in man. Br J Radiol 1980; 53: 271-278.
21. Meistrich ML. Effects of chemotherapy and radiotherapy on spermatogenesis. Eur Urol 1993; 23: 136-141.
22. Chiarelli AM, et al. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology 2000; 11: 161-166.
23. Chiarelli AM, et al. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 1999; 150: 245-254.
24. Abrahamsen AF, et al. Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease. Acta Oncol 1999; 38: 511-515.
25. Khoo VS, et al. Thyroid dysfunction after mantle irradiation of Hodgkin's disease patients. Australas Radiol 1998; 42: 52-57.
26. Livesey EA, Brook CG. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 1989; 64: 593-595.
27. Harten G, et al. Slight impairment of psychomotor skills in children after treatment of acute lymphoblastic leukemia. Eur J Pediatr 1984; 142: 189-197.
28. Hertzberg H, et al. CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL - an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group. Med Pediatr Oncol 1997; 28: 387-400.
29. Dowell-Re J, et al. Absence of synergistic effects of CNS treatments on neuropsychologic test performance among children. J Clin Oncol 1991; 9: 1029-1036.
30. Ochs J, et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 1991; 9: 145-151.
31. Loning L, et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 2000; 95: 2770-2775.
32. Kaatsh P, et al. Childhood malignancies in Germany - methods and results of a nationwide registry. Eur J CAncer 1995; 31A: 993-999.